Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy

Journal of Human Hypertension

Volumn 11, Issue 1, 1997, Pages 35-38

  Bakris, G ^a,b,c   White, D ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c RUSH UNIVERSITY   (United States)

Author keywords

ACE inhibitor; Calcium antagonist; Diabetic nephropathy; Proteinuria

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL MODEL; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DISEASE COURSE; HUMAN; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEINURIA;

EID: 0030942920     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000398     Document Type: Conference Paper

References (35)

1. Nelson RG, Knowler WC, Pettitt DJ, Bennett PH. Kidney diseases in diabetes. In: Diabetes In America. National Institutes of Health Pub No 95-1468, 2nd edition, 1995, pp 349-400.
2. Rodby R, Firth LM, Lewis EJ. The Collaborative Study Group. An economic analysis of captopril in the treatment of diabetic nephropathy. Diabetes Care 1996; 19: 1051-1061.
3. Simeon G, Bakris GL. Socioeconomic impact of diabetic nephropathy: can we improve outcome? J Hypertens (in press).
4. Maki DD, Ma JZ, Louis TA, Kasiske BL. Effects of antihypertensive agents on the kidney. Arch Intern Med 1995; 155: 1073-1082.
5. Weidmann P et al. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis. Nephrol Dial Transpl 1995; 10 (Suppl 9): 39-45.
6. Gansevoort RT et al. Antiproteinuric effect of blood pressure lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 1995; 10: 1963-1974.
7. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD for the Collaborative Study Group. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
8. Bakris GL et al. Effects of nondihydropyridine calcium antagonists on progression of nephropathy resulting from noninsulin dependent diabetes: a six year follow-up study prospective study. Kidney Int 1996; 50: 1641-1650.
9. National High Blood Pressure Education Program Working Group on Hypertension and Renal Disease. 1995 Update of the working group reports on chronic renal failure and renovascular hypertension. Arch Intern Med 1996; 156: 1938-1949.
10. Bakris GL. Microalbuminuria: Prognostic Implications. Cur Opinion Nephrol Hypertens 1996; 7 (in press).
11. Kilaru P, Bakris GL. Microalbuminuria and progressive renal disease. J Hum Hypertens 1994; 8: 809-817.
12. Brown SA, Walton CL, Crawford P, Bakris GL. Long-term effects of different anti-hypertensive regimens on renal hemodynamics and proteinuria. Kidney Int 1993; 43: 1210-1218.
13. Abbott K, Smith AC, Bakris GL. Effects of dihydropyridine calcium antagonists on albuminuria in diabetic subjects. J Clin Pharmacol 1996; 36: 274-279.
14. Bakris GL, Smith AC. Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Annals of Int Med 1996; 125: 201-203.
15. Bakris GL, Williams B. ACE inhibitors and calcium antagonists alone or combined: is there a difference on progression of diabetic renal disease? J Hypertens 1995; 13 (Suppl 2): S95-S101.
16. Bakris GL. Hypertension in diabetic patients: an overview of interventional studies to preserve renal function. Am J Hypertens 1993; 6 (Suppl 4): 140S-147S.
17. Griffin KA, Picken MM, Bidani AK. Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 1995; 96: 793-800.
18. Picken M, Griffin K, Bakris GL, Bidani A. Comparative effects of four different calcium antagonists on progression of renal disease in a remnant kidney model. J Am Soc Nephrol 1996; 7: 1586 (Abstract).
19. Gaber L, Walton C, Brown S, Bakris GL. Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs. Kidney Int 1994; 46: 161-169.
20. Bakris GL, Copley JB, Vicknair N. Blood pressure reduction and progression of diabetic nephropathy in African-Americans: A five year follow-up study. Hypertension 1992; March.
21. Kilaru P, Bakris GL. ACE inhibition or calcium-channel blockade: renal implications of combination therapy versus a single agent. J Cardiovasc Pharmacol 1996; 28: 534-544.
22. Jyothirmayi GN, Reddi AS. Effect of diltiazem on glomerular heparin sulfate and albuminuria in diabetic rats. Hypertension 1993; 21: 765-802.
23. Bakris GL et al. Renal hemodynamic and antiproteinuric response to an ACE inhibitor, trandolopril or calcium antagonist, verapamil, alone or in fixed dose combination in patients with diabetic nephropathy: a randomized multicentered study. J Am Soc Nephrol 1996; 7: 1546 (Abstract).
24. Perna A, Remuzzi G. Abnormal permeability to proteins and glomerular lesions: a meta-analysis of experimental and human studies. Am J Kidney Dis 1996; 27: 34-41.
25. Velussi M et al. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996; 45: 216-222.
26. Bakris GL. The role of calcium channel blockers and progression of kidney disease. J Nephrol (in press).
27. Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989; 38: 1077-1081.
28. Lash JP, Bakris GL. Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy. Nephrol, Dialysis Transpl 1995; 10 (Suppl 9): 56-62.
29. Taft JL et al. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 1994; 43: 1046-1051.
30. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. Arch Intern Med 1996; 156: 286-289.
31. Zucchelli P et al. Long term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452-458.
32. Munter K, Hergenroder S, Jochims K, Kirchengast M. Individual and combined effects of verapamil or trandolapril on glomerular morphology and function in the stroke prone rat. J Am Soc Nephrol 1996; 7: 681-686.
33. Picken M, Griffin K, Bakris GL, Bidani A. Effects of a fixed dose combination of either amlodipine, benazapril or their combination on glomerulosclerosis and proteinuria. Kidney Int (in press).
34. Bakris GL. Combination therapy for hypertension and renal disease in diabetes. In: Mogensen CE (ed). The Kidney in Hypertension and Diabetes Mellitus 3rd edition Kluwer Academic Publ, 1997, pp 561-568.
35. Epstein M, Bakris GL. Newer approaches to antihypertensive therapy using fixed dose combination therapy: future perspectives. Arch Intern Med 1996; 156: 1969-1978.